Abstract
Introduction
Herniated lumbar disc is a displacement of disc material (nucleus pulposus or annulus fibrosus) beyond the intervertebral disc space. The highest prevalence is among people aged 30 to 50 years, with a male to female ratio of 2:1.
Methods and outcomes
We conducted a systematic overview, aiming to answer the following clinical question: What are the effects of injection interventions for clinical symptoms of sciatica relating to confirmed or suspected herniated lumbar disc? We searched: Medline, Embase, The Cochrane Library, and other important databases up to May 2014 (BMJ Clinical Evidence overviews are updated periodically; please check our website for the most up-to-date version of this overview).
Results
At this update, searching of electronic databases retrieved 320 studies. After deduplication and removal of conference abstracts, 240 records were screened for inclusion in the overview. Appraisal of titles and abstracts led to the exclusion of 171 studies and the further review of 69 full publications. Of the 69 full articles evaluated, four systematic reviews and one RCT were added at this update. We performed a GRADE evaluation for 13 PICO combinations.
Conclusions
In this systematic overview, we categorised the efficacy for four interventions based on information about the effectiveness and safety of epidural corticosteroid injection (with or without local anaesthetic), epidural injection with local anaesthetic alone, nerve root block with corticosteroid injection (with or without local anaesthetic), and nerve root block with local anaesthetic injection alone.
Key Points
Herniated lumbar disc is a displacement of disc material (nucleus pulposus or annulus fibrosus) beyond the intervertebral disc space.
The highest prevalence is among people aged 30 to 50 years, with a male to female ratio of 2:1.
Previous BMJ Clinical Evidence overviews on this topic have evaluated the effectiveness of a broad range of interventions, including drug treatment and surgery. However, for this update we have focused on injection treatments as these are in widespread clinical use, particularly for patients with severe initial leg pain or significant persistent leg pain in the absence of neurological deficit, short of the threshold for surgery at 3 months.
We evaluated evidence from RCTs and systematic reviews of RCTs on the effectiveness of epidural corticosteroid injection (with or without local anaesthetic), epidural injection with local anaesthetic alone, nerve root block with corticosteroid injection (with or without local anaesthetic), and nerve root block with local anaesthetic injection alone.
We found several RCTs that assessed a range of different measures of symptom improvement and found inconsistent results, so we are unable to draw firm conclusions on effects of epidural injections of corticosteroids.
Epidural corticosteroid injection (with or without local anaesthetic) may be more effective at improving leg pain in the short term (up to 6 weeks) compared with no epidural injection, but may be no more effective in the longer term (approximately 6 weeks to 14 months) in people with clinical symptoms of sciatica relating to confirmed or suspected lumbar disc herniation.
Epidural corticosteroid injection (with or without local anaesthetic) may be no more effective in the longer term (over 5 weeks) at improving disability or functional outcomes, such as straight leg raising and lumbar flexion, compared with no epidural corticosteroid injection in people with clinical symptoms of sciatica relating to confirmed or suspected lumbar disc herniation.
We found no direct information from RCTs about epidural injection with local anaesthetic alone in the treatment of people with clinical symptoms of sciatica relating to confirmed or suspected lumbar herniated lumbar disc.
We don't know whether injection of corticosteroid as a nerve block, with or without local anaesthetic, is more effective than no nerve block at improving pain or need for surgery in people with clinical symptoms of sciatica relating to confirmed or suspected lumbar herniated lumbar disc.
We don't know whether nerve root block with local anaesthetic alone is more effective than no nerve root block at improving pain outcomes or need for surgery in people with sciatica relating to confirmed herniated lumbar disc. We only found one RCT evaluating this intervention.
As in many areas of spinal practice, lack of high-quality clinical trials makes evidence-based clinical practice difficult. Many relevant trials have heterogeneous entry criteria and outcome measures.
Clinical context
General background
Lumbar disc herniation is a relatively common, painful, and disabling condition, but has a reasonably good outcome with expedient treatment. Most patients with severe symptoms, needing additional care than provided by their general practitioner, will improve on medication and with physiotherapy input. Patients with sciatica that is initially severe or persistent in the absence of neurological deficit may be good candidates for injection treatments. A small number of patients with persistent nerve root pain beyond 3 months from onset, progressive neurological deficit, or cauda equina syndrome are candidates for surgery.
Focus of the review
There is a reasonable evidence base surrounding the use of medication and also about the specific role of surgery in this condition. Injections have been in widespread clinical practice for many years, and yet there has been a general recognition that the evidence base does not support their clinical use, although there is evidence that injections may offer effective pain relief from sciatica in the short term. This is one area of medicine where the pragmatic clinical approach needs to be supported by relevant clinical evidence.
Comments on evidence
As in many areas of spinal practice, lack of high-quality clinical trials makes evidence-based clinical practice difficult. Many relevant trials have heterogeneous entry criteria and outcome measures. External validity may at times be a problem. Pragmatically, injection treatments are used to treat severe leg pain due to lumbar spinal nerve root involvement, especially when symptoms do not improve in the first 2 months and despite primary care treatments in the form of medication and physiotherapy. The primary outcome measures should be early relief of leg pain and improvement in function. This should be compared with other conservative interventions used in such presentations, and there should be long-term follow-up.
Search and appraisal summary
The update literature search for this overview was carried out from the date of the last search, June 2010, to May 2014. A back search from 1966 was performed for the new options added to the scope at this update. For more information on the electronic databases searched and criteria applied during assessment of studies for potential relevance to the overview, please see the Methods section. Searching of electronic databases retrieved 320 studies. After deduplication and removal of conference abstracts, 240 records were screened for inclusion in the overview. Appraisal of titles and abstracts led to the exclusion of 171 studies and the further review of 69 full publications. Of the 69 full articles evaluated, four systematic reviews and one RCT were added at this update.
About this condition
Definition
Herniated lumbar disc is a displacement of disc material (nucleus pulposus or annulus fibrosus) beyond the intervertebral disc space.[1] The diagnosis can be confirmed by radiological examination. However, MRI findings of herniated disc are not always accompanied by clinical symptoms.[2] [3] This overview covers treatment of people with clinical symptoms of sciatica relating to confirmed or suspected disc herniation. It does not include treatment of people with spinal cord compression or people with cauda equina syndrome, which require emergency intervention. The management of non-specific acute low back pain and chronic low back pain are covered elsewhere in BMJ Clinical Evidence. Injection interventions We have focused on injection treatments for this update. Essentially, these injections involve the instillation of either local anaesthetic or corticosteroid, or both, into the region where the presumed inflammatory pathology due to the disc herniation is irritating the nerve root and producing leg pain, often referred to in the literature and by clinicians and patients as sciatica. Epidural injections can be administered by the lumbar, caudal, or transforaminal route. The lumbar or interlaminar route is typically performed at L3-L4 or L4-L5. The caudal route involves a needle being passed through the caudal membrane, and higher volumes of injection are instilled so as to reach the lumbosacral junction. Transforaminal epidural injection involves a needle being inserted through an oblique approach into the region of the intervertebral foramen and injecting around the dura. Selective nerve root block is a similar injection but, following contrast administration, the injection is essentially into the nerve root sleeve and extra-spinally rather than getting into the epidural space. Typically, these interventions are used early in the evolution of a disc herniation, either for severe initial leg pain or for persistent leg pain short of the threshold for surgery at approximately 3 months. In current clinical practice, they may be repeated providing the first injection produced adequate pain relief, and depending on a variety of other patient-related factors, including the presence or absence of medical comorbidities.
Incidence/ Prevalence
The prevalence of symptomatic herniated lumbar disc is about 1% to 3% in Finland and Italy, depending on age and sex.[4] The highest prevalence is among people aged 30 to 50 years,[5] with a male to female ratio of 2:1.[6] In people aged 25 to 55 years, about 95% of herniated discs occur at the lower lumbar spine (L4-L5 and L5-S1 level); disc herniation above this level is more common in people aged over 55 years.[7] [8]
Aetiology/ Risk factors
Radiographical evidence of disc herniation does not reliably predict low back pain in the future, or correlate with symptoms; 19% to 27% of people without symptoms have disc herniation on imaging.[2] [9] Risk factors for disc herniation include smoking (OR 1.7, 95% CI 1.0 to 2.5), weight-bearing sports (e.g., weight lifting, hammer throw), and certain work activities, such as repeated lifting. Driving a motor vehicle has been suggested to be a risk factor for disc herniation, although evidence is inconclusive (OR 1.7, 95% CI 0.2 to 2.7).[6] [10] [11]
Prognosis
The natural history of disc herniation is difficult to determine because most people take some form of treatment for their back pain and a formal diagnosis is not always made.[6] Sequential MRIs have shown that the herniated portion of the disc tends to regress over time, with partial to complete resolution after 6 months in two-thirds of people.[12]
Aims of intervention
To relieve pain; increase mobility and function; improve quality of life; and minimise adverse effects of treatments.
Outcomes
Pain, including global symptom relief; functional improvement (measured by e.g., Roland Morris Disability Questionnaire; Oswestry Disability Index; Hannover Functional Ability Questionnaire), return to work; patient perception of improvement; need for surgery; quality of life; adverse effects.
Methods
Search strategy BMJ Clinical Evidence search and appraisal date May 2014. Databases used to identify studies for this systematic overview include: Medline 1966 to May 2014, Embase 1980 to May 2014, The Cochrane Database of Systematic Reviews 2014, issue 5 (1966 to date of issue), the Database of Abstracts of Reviews of Effects (DARE), and the Health Technology Assessment (HTA) database. Inclusion criteria Study design criteria for inclusion in this systematic overview were systematic reviews and RCTs published in English, at least single-blinded, and containing more than 20 individuals, of whom more than 80% were followed up. There was no minimum length of follow-up. We excluded all studies described as ‘open’, ‘open label’, or not blinded unless blinding was impossible. BMJ Clinical Evidence does not necessarily report every study found (e.g., every systematic review). Rather, we report the most recent, relevant, and comprehensive studies identified through an agreed process involving our evidence team, editorial team, and expert contributors. Evidence evaluation A systematic literature search was conducted by our evidence team, who then assessed titles and abstracts, and finally selected articles for full text appraisal against inclusion and exclusion criteria agreed a priori with our expert contributors. In consultation with the expert contributors, studies were selected for inclusion and all data relevant to this overview extracted into the benefits and harms section of the overview. In addition, information that did not meet our pre-defined criteria for inclusion in the benefits and harms section may have been reported in the 'Further information on studies' or 'Comment' section. Adverse effects All serious adverse effects, or those adverse effects reported as statistically significant, were included in the harms section of the overview. Pre-specified adverse effects identified as being clinically important were also reported, even if the results were not statistically significant. Although BMJ Clinical Evidence presents data on selected adverse effects reported in included studies, it is not meant to be, and cannot be, a comprehensive list of all adverse effects, contraindications, or interactions of included drugs or interventions. A reliable national or local drug database must be consulted for this information. Comment and Clinical guide sections In the Comment section of each intervention, our expert contributors may have provided additional comment and analysis of the evidence, which may include additional studies (over and above those identified via our systematic search) by way of background data or supporting information. As BMJ Clinical Evidence does not systematically search for studies reported in the Comment section, we cannot guarantee the completeness of the studies listed there or the robustness of methods. Our expert contributors add clinical context and interpretation to the Clinical guide sections where appropriate. Structural changes this update At this update, we have removed the following previously reported questions: What are the effects of drug treatments for herniated lumbar disc? What are the effects of non-drug treatments for herniated lumbar disc? What are the effects of surgery for herniated lumbar disc? Data and quality To aid readability of the numerical data in our overviews, we round many percentages to the nearest whole number. Readers should be aware of this when relating percentages to summary statistics such as relative risks (RRs) and odds ratios (ORs). BMJ Clinical Evidence does not report all methodological details of included studies. Rather, it reports by exception any methodological issue or more general issue that may affect the weight a reader may put on an individual study, or the generalisability of the result. These issues may be reflected in the overall GRADE analysis. We have performed a GRADE evaluation of the quality of evidence for interventions included in this review (see table). The categorisation of the quality of the evidence (high, moderate, low, or very low) reflects the quality of evidence available for our chosen outcomes in our defined populations of interest. These categorisations are not necessarily a reflection of the overall methodological quality of any individual study, because the Clinical Evidence population and outcome of choice may represent only a small subset of the total outcomes reported, and population included, in any individual trial. For further details of how we perform the GRADE evaluation and the scoring system we use, please see our website (www.clinicalevidence.com).
Table.
GRADE Evaluation of interventions for Herniated lumbar disc: injection interventions for sciatica.
| Important outcomes | Functional improvement, Need for surgery, Pain, Patient perception of improvement, Quality of life | ||||||||
| Studies (Participants) | Outcome | Comparison | Type of evidence | Quality | Consistency | Directness | Effect size | GRADE | Comment |
| What are the effects of injection interventions for clinical symptoms of sciatica relating to confirmed or suspected herniated lumbar disc? | |||||||||
| 5 (545) | Pain | Epidural corticosteroid injection (with or without local anaesthetic) versus no epidural corticosteroid injection | 4 | –1 | –1 | 0 | 0 | Low | Quality point deducted for incomplete reporting of results; consistency point deducted for different results at different end points |
| 3 (471) | Functional improvement | Epidural corticosteroid injection (with or without local anaesthetic) versus no epidural corticosteroid injection | 4 | –1 | 0 | 0 | 0 | Moderate | Quality point deducted for incomplete reporting of results |
| 5 (417) | Patient perception of improvement | Epidural corticosteroid injection (with or without local anaesthetic) versus no epidural corticosteroid injection | 4 | 0 | –1 | –1 | 0 | Low | Consistency point deducted for different results at different end points; directness point deducted for not defining outcome measured |
| 1 (158) | Need for surgery | Epidural corticosteroid injection (with or without local anaesthetic) versus no epidural corticosteroid injection | 4 | –2 | 0 | –1 | 0 | Very low | Quality point deducted for sparse data and incomplete reporting of results; directness point deducted for narrow included population |
| 1 (36) | Pain | Epidural corticosteroid injection (with or without local anaesthetic) plus conservative non-operative treatment versus conservative treatment alone | 4 | –1 | 0 | –1 | 0 | Low | Quality point deducted for sparse data; directness point deducted for wide range of interventions used in comparison, making the results difficult to apply in clinical practice |
| 1 (36) | Functional improvement | Epidural corticosteroid injection (with or without local anaesthetic) plus conservative non-operative treatment versus conservative treatment alone | 4 | –1 | 0 | –1 | 0 | Low | Quality point deducted for sparse data; directness point deducted for wide range of interventions used in comparison, making the results difficult to apply in clinical practice |
| 1 (36) | Need for surgery | Epidural corticosteroid injection (with or without local anaesthetic) plus conservative non-operative treatment versus conservative treatment alone | 4 | –1 | 0 | –1 | 0 | Low | Quality point deducted for sparse data; directness point deducted for wide range of interventions used in comparison, making the results difficult to apply in clinical practice |
| 1 (100) | Pain | Epidural corticosteroid injection (with or without local anaesthetic) versus discectomy | 4 | –2 | –1 | 0 | 0 | Very low | Quality points deducted for sparse data and incomplete reporting of results; consistency point deducted for different results at different end points |
| 1 (100) | Functional improvement | Epidural corticosteroid injection (with or without local anaesthetic) versus discectomy | 4 | –2 | –1 | 0 | 0 | Very low | Quality points deducted for sparse data and incomplete reporting of results; consistency point deducted for different results at different end points |
| 3 (274) | Pain | Nerve root block with corticosteroid injection (with or without local anaesthetic) versus no nerve root block corticosteroid injection | 4 | –2 | 0 | 0 | 0 | Low | Quality points deduced for incomplete reporting of results and methodological flaws (unclear method of randomisation in one RCT) |
| 1 (65) | Need for surgery | Nerve root block with corticosteroid injection (with or without local anaesthetic) versus no nerve root block corticosteroid injection | 4 | –2 | 0 | 0 | 0 | Low | Quality points deducted for sparse data and incomplete reporting of results |
| 1 (64) | Pain | Nerve block with local anaesthetic versus no nerve block | 4 | –2 | 0 | 0 | 0 | Low | Quality points deducted for sparse data and incomplete reporting of results |
| 1 (64) | Need for surgery | Nerve block with local anaesthetic versus no nerve block | 4 | –2 | 0 | 0 | 0 | Low | Quality points deducted for sparse data and incomplete reporting of results |
We initially allocate 4 points to evidence from RCTs, and 2 points to evidence from observational studies. To attain the final GRADE score for a given comparison, points are deducted or added from this initial score based on preset criteria relating to the categories of quality, directness, consistency, and effect size. Quality: based on issues affecting methodological rigour (e.g., incomplete reporting of results, quasi-randomisation, sparse data [<200 people in the analysis]). Consistency: based on similarity of results across studies. Directness: based on generalisability of population or outcomes. Effect size: based on magnitude of effect as measured by statistics such as relative risk, odds ratio, or hazard ratio.
Glossary
- Cauda equina syndrome
Compression of the cauda equina, causing symptoms that include changes in perineal sensation (saddle anaesthesia) and loss of sphincter control. The cauda equina is a collection of spinal roots descending from the lower part of the spinal cord, which occupy the vertebral canal below the spinal cord.
- Likert Scale
A method of measuring attitudes that asks respondents to indicate their degree of agreement or disagreement with statements, according to a scoring system (usually 5 points). For example, subjects may be asked to rate their pain on a scale where none = 0, mild = 1, moderate = 2, severe = 3, and extreme = 4.
- Low-quality evidence
Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
- Moderate-quality evidence
Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
- Oswestry Disability Index
Back-specific, self-reported questionnaire measuring pain and function in completing physical and social activities. The scale score ranges from 0 (no disability) to 100 (maximum disability).
- Roland Morris Disability Questionnaire
A 24-item, self-reported, disability scale specific to back pain recommended for use in primary care and community studies. Measures daily function in completing activities affected by back pain. The scale score ranges from 0 (no disability) to 24 (severe disability).
- Very low-quality evidence
Any estimate of effect is very uncertain.
Chronic low back pain
Non-specific acute low back pain
Disclaimer
The information contained in this publication is intended for medical professionals. Categories presented in Clinical Evidence indicate a judgement about the strength of the evidence available to our contributors prior to publication and the relevant importance of benefit and harms. We rely on our contributors to confirm the accuracy of the information presented and to adhere to describe accepted practices. Readers should be aware that professionals in the field may have different opinions. Because of this and regular advances in medical research we strongly recommend that readers' independently verify specified treatments and drugs including manufacturers' guidance. Also, the categories do not indicate whether a particular treatment is generally appropriate or whether it is suitable for a particular individual. Ultimately it is the readers' responsibility to make their own professional judgements, so to appropriately advise and treat their patients. To the fullest extent permitted by law, BMJ Publishing Group Limited and its editors are not responsible for any losses, injury or damage caused to any person or property (including under contract, by negligence, products liability or otherwise) whether they be direct or indirect, special, incidental or consequential, resulting from the application of the information in this publication.
Contributor Information
Joanne L Jordan, Arthritis Research UK Primary Care Centre, Primary Care Sciences, Keele University, Keele, UK.
Kika Konstantinou, Arthritis Research UK Primary Care Centre, Primary Care Sciences, Keele University, Keele, UK.
John O'Dowd, RealHealth Institute, London, UK.
References
- 1.Fardon DF, Milette PC. Nomenclature and classification of lumbar disc pathology: recommendations of the Combined Task Forces of the North American Spine Society, American Society of Spine Radiology, and American Society of Neuroradiology. Spine 2001;26:E93–E113. [DOI] [PubMed] [Google Scholar]
- 2.Boden SD. The use of radiographic imaging studies in the evaluation of patients who have degenerative disorders of the lumbar spine. J Bone Joint Surg Am 1996;78:114–125. [DOI] [PubMed] [Google Scholar]
- 3.Borenstein DG, O'Mara JW Jr, Boden SD, et al. The value of magnetic resonance imaging of the lumbar spine to predict low-back pain in asymptomatic subjects. J Bone Joint Surg Am 2001;83-A:1306–1311. [DOI] [PubMed] [Google Scholar]
- 4.Andersson G. Epidemiology of spinal disorders. In: Frymoyer JW, Ducker TB, Hadler NM, et al, eds. The adult spine: principles and practice. New York, NY: Raven Press, 1997:93–141. [Google Scholar]
- 5.Heliovaara M. Epidemiology of sciatica and herniated lumbar intervertebral disc. Helsinki, Finland: The Social Insurance Institution, 1988. [Google Scholar]
- 6.Postacchini F, Cinotti G. Etiopathogenesis. In: Postacchini F, ed. Lumbar disc herniation. New York: Spring-Verlag, 1999:151–164. [Google Scholar]
- 7.Friberg S, Hirsch C. Anatomical and clinical studies on lumbar disc degeneration. Acta Orthop Scand 1949;19:222–242. [DOI] [PubMed] [Google Scholar]
- 8.Schultz A, Andersson G, Ortengren R, et al. Loads on the lumbar spine. Validation of a biomechanical analysis by measurements of intradiscal pressures and myoelectric signals.J Bone Joint Surg Am 1982;64:713–720. [PubMed] [Google Scholar]
- 9.Jensen MC, Brant-Zawadzki MN, Obuchowski N, et al. Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med 1994;331:69–73. [DOI] [PubMed] [Google Scholar]
- 10.Kelsey JL, Githens P, O'Connor T, et al. Acute prolapsed lumbar intervertebral disc: an epidemiologic study with special reference to driving automobiles and cigarette smoking. Spine 1984;9:608–613. [DOI] [PubMed] [Google Scholar]
- 11.Pedrini-Mille A, Weinstein JN, Found EM, et al. Stimulation of dorsal root ganglia and degradation of rabbit annulus fibrosus. Spine 1990;15:1252–1256. [DOI] [PubMed] [Google Scholar]
- 12.Deyo RA, Weinstein JN. Low back pain. N Engl J Med 2001;344:363–370. [DOI] [PubMed] [Google Scholar]
- 13.Vroomen PC, de Krom MC, Slofstra PD, et al. Conservative treatment of sciatica: a systematic review. J Spinal Disord 2000;13:463–469. [DOI] [PubMed] [Google Scholar]
- 14.Conn A, Buenaventura RM, Datta S, et al. Systematic review of caudal epidural injections in the management of chronic low back pain. Pain Physician 2009;12:109–135. [PubMed] [Google Scholar]
- 15.Parr AT, Diwan S, Abdi S, et al. Lumbar interlaminar epidural injections in managing chronic low back and lower extremity pain: a systematic review. Pain Physician 2009;12:163–188. [PubMed] [Google Scholar]
- 16.Lewis R, Williams N, Matar HE, et al. The clinical effectiveness and cost-effectiveness of management strategies for sciatica: systematic review and economic model. Health Technol Assess 2011;15:1–578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Valat JP, Giraudeau B, Rozenberg S, et al. Epidural corticosteroid injections for sciatica: a randomised, double blind, controlled clinical trial. Ann Rheum Dis 2003;62:639–643. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Buchner M, Zeifang F, Brocai DR, et al. Epidural corticosteroid injection in the conservative management of sciatica. Clin Orthop Relat Res 2000;375:149–156. [DOI] [PubMed] [Google Scholar]
- 19.Buttermann GR. Treatment of lumbar disc herniation: epidural steroid injection compared with discectomy. A prospective, randomized study. J Bone Joint Surg Am 2004;86-A:670–679. [PubMed] [Google Scholar]
- 20.Gibson JN, Waddell G. Surgical interventions for lumbar disc prolapse. In: The Cochrane Library, Issue 5, 2014. Chichester, UK: John Wiley & Sons Ltd. Search date 2007. 17443505 [Google Scholar]
- 21.DePalma MJ, Bhargava A, Slipman CW. A critical appraisal of the evidence for selective nerve root injection in the treatment of lumbosacral radiculopathy. Arch Phys Med Rehabil 2005;86:1477–1483. [DOI] [PubMed] [Google Scholar]
- 22.Manchikanti L, Benyamin RM, Falco FJ, et al. Do epidural injections provide short- and long-term relief for lumbar disc herniation? A systematic review. Clin Orthop Relat Res 2015;473:1940–1956. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Benny B, Azari P. The efficacy of lumbosacral transforaminal epidural steroid injections: A comprehensive literature review. J Back Musculoskel Rehabil 2011;24:67–76. [DOI] [PubMed] [Google Scholar]
- 24.Ghahreman A, Ferch R, Bogduk N. The efficacy of transforaminal injection of steroids for the treatment of lumbar radicular pain. Pain Med 2010;11:1149–1168. [DOI] [PubMed] [Google Scholar]
